Fernanda Lemos

Dr. Fernanda Lemos


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2019 in Science Signaling
Verified
Journal Article
Closed access
PDF file
IKIvana Y. Kuo
Ivana Y. Kuo
ABAllison L. Brill
Allison L. Brill
FLFernanda Lemos
Fernanda Lemos
JJJason Y. Jiang
Jason Y. Jiang
JFJeffrey L. Falcone
Jeffrey L. Falcone
BEBarbara E. Ehrlich
Barbara E. Ehrlich
Mitochondria and the endoplasmic reticulum (ER) have an intimate functional relationship due to tethering proteins that bring their membranes in close (~30 nm) apposition. One function of this interorganellar junction is to increase the efficiency of Ca2+ transfer into mitochondria, thus stimulating mitochondrial respiration. Here, we showed that the ER cation-permeant channel polycystin 2 (PC2) functions to reduce mitochondria-ER contacts. In cell culture models, PC2 knockdown led to a 50% increase in mitofusin 2 (MFN2) expression, an outer mitochondrial membrane GTPase. Live-cell super-resolution and electron microscopy analyses revealed enhanced MFN2-dependent tethering between the ER and mitochondria in PC2 knockdown cells. PC2 knockdown also led to increased ER-mediated mitochondrial Ca2+ signaling, bioenergetic activation, and mitochondrial density. Mutation or deletion of the gene encoding for PC2 results in autosomal dominant polycystic kidney disease (ADPKD), a condition characterized by numerous fluid-filled cysts. In cell culture models and mice with kidney-specific PC2 knockout, knockdown of MFN2 rescued defective mitochondrial Ca2+ transfer and diminished cell proliferation in kidney cysts. Consistent with these results, cyst-lining epithelial cells from human ADPKD kidneys had a twofold increase in mitochondria and MFN2 expression. Our data suggest that PC2 normally serves to limit key mitochondrial proteins at the ER-mitochondrial interface and acts as a checkpoint for mitochondrial biogenesis and bioenergetics. Loss of this regulation may contribute to the increased oxidative metabolism and aberrant cell proliferation typical of kidney cysts in ADPKD.

1 April 2008 in Phytomedicine
Verified
Journal Article
Closed access
VMVanessa J. Mello
Vanessa J. Mello
MGMarco Túlio R. Gomes
Marco Túlio R. Gomes
FLFernanda Lemos
Fernanda Lemos
JDJose L. Delfino
Jose L. Delfino
SASilvia P. Andrade
Silvia P. Andrade
CSCarlos E. Salas
Carlos E. Salas

17 July 2019 in Gut
Verified
Journal Article
Open access
PDF file
MGMateus T Guerra
Mateus T Guerra
RFRodrigo M Florentino
Rodrigo M Florentino
AFAndressa Franca
Andressa Franca
AFAntonio C Lima Filho
Antonio C Lima Filho
MSMarcone L dos Santos
Marcone L dos Santos
MLMaria Fatima Leite
Maria Fatima Leite
Background & objectives: Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide. Several types of chronic liver disease predispose to HCC, and several different signalling pathways have been implicated in its pathogenesis, but no common molecular event has been identified. Ca2+signalling regulates the proliferation of both normal hepatocytes and liver cancer cells, so we investigated the role of intracellular Ca2+release channels in HCC.Design: Expression analyses of the type 3 isoform of the inositol 1, 4, 5-trisphosphate receptor (ITPR3) in human liver samples, liver cancer cells and mouse liver were combined with an evaluation of DNA methylation profiles of ITPR3 promoter in HCC and characterisation of the effects of ITPR3 expression on cellular proliferation and apoptosis. The effects ofde novoITPR3 expression on hepatocyte calcium signalling and liver growth were evaluated in mice.Results: ITPR3 was absent or expressed in low amounts in hepatocytes from normal liver, but was expressed in HCC specimens from three independent patient cohorts, regardless of the underlying cause of chronic liver disease, and its increased expression level was associated with poorer survival. TheITPR3gene was heavily methylated in control liver specimens but was demethylated at multiple sites in specimens of patient with HCC. Administration of a demethylating agent in a mouse model resulted in ITPR3 expression in discrete areas of the liver, and Ca2+signalling was enhanced in these regions. In addition, cell proliferation and liver regeneration were enhanced in the mouse model, and deletion ofITPR3from human HCC cells enhanced apoptosis.Conclusions: These results provide evidence thatde novoexpression of ITPR3 typically occurs in HCC and may play a role in its pathogenesis.

1 January 2018 in Cell Calcium
Verified
Journal Article
Closed access
FLFernanda Lemos
Fernanda Lemos
BEBarbara E. Ehrlich
Barbara E. Ehrlich

1 October 2014 in Peptides
Verified
Journal Article
Closed access
JAJoão Marcus Oliveira Andrade
João Marcus Oliveira Andrade
FLFernanda Lemos
Fernanda Lemos
SPSimone da Fonseca Pires
Simone da Fonseca Pires
RMRuben Dario Sinisterra Millán
Ruben Dario Sinisterra Millán
FSFrederico De Sousa
Frederico De Sousa
Sérgio Henrique Sousa SantosSérgio Henrique Sousa Santos
Sérgio Henrique Sousa Santos

Verified
Journal Article
Open access
PDF file
KSKemper Nunes dos Santos
Kemper Nunes dos Santos
RFRodrigo M Florentino
Rodrigo M Florentino
AFAndressa França
Andressa França
AFAntônio Carlos Melo Lima Filho
Antônio Carlos Melo Lima Filho
MSMarcone Loiola dos Santos
Marcone Loiola dos Santos
MLM. Fatima Leite
M. Fatima Leite
Alcoholic liver disease (ALD) is a highly prevalent spectrum of pathologies caused by alcohol overconsumption. Morbidity and mortality related to ALD are increasing worldwide, thereby demanding strategies for early diagnosis and detection of ALD predisposition. A potential candidate as a marker for ALD susceptibility is the transcription factor nuclear factor erythroid-related factor 2 (Nrf2), codified by the nuclear factor erythroid 2-related factor 2 gene (NFE2L2). Nrf2 regulates expression of proteins that protect against oxidative stress and inflammation caused by alcohol overconsumption. Here, we assessed genetic variants of NFE2L2 for association with ALD. Specimens from patients diagnosed with cirrhosis caused by ALD were genotyped for three NFE2L2 single nucleotide polymorphisms (SNP) (SNPs: rs35652124, rs4893819, and rs6721961). Hematoxylin & eosin and immunohistochemistry were performed to determine the inflammatory score and Nrf2 expression, respectively. SNPs rs4893819 and rs6721961 were not specifically associated with ALD, but analysis of SNP rs35652124 suggested that this polymorphism predisposes to ALD. Furthermore, SNP rs35652124 was associated with a lower level of Nrf2 expression. Moreover, liver samples from ALD patients with this polymorphism displayed more severe inflammatory activity. Together, these findings provide evidence that the SNP rs35652124 variation in the Nrf2-encoding gene NFE2L2 is a potential genetic marker for susceptibility to ALD.